AstraZeneca has acknowledged that its Covid vaccine can trigger a rare side effect involving blood clotting. Covishield, used widely in India, is based on AstraZeneca's vaccine. This admission comes in the context of a multimillion-pound class action lawsuit alleging harm or death from the vaccine. AstraZeneca has acknowledged that its vaccine can cause Thrombosis with Thrombocytopenia Syndrome (TTS). Legal action was initiated by Jamie Scott, who suffered a permanent brain injury. In total, 51 cases have been filed seeking damages amounting to $125.36 million. This development with AstraZeneca's vaccine underscores the importance of continued research, monitoring, and transparency in vaccine safety.

#AstraZeneca #Covishield #CovidVaccine #SideEffects #BloodClots #Thrombosis #Thrombocytopenia #VaccineSafety #ClassActionLawsuit #JamieScott #Transparency #Healthcare #Research #Monitoring

About us:
The Free Press Journal is one of the oldest English Daily newspapers from Mumbai
with a rich heritage of over 90 years. FPJ stands for quality journalism and objective and unbiased opinions on the issues that impact our daily lives.

Follow us on Google News for #BreakingNews and #LatestNews Updates :

Free Press Journal : [ Ссылка ]

Follow us on Social Media :
Like us on Facebook :

/ tcqcwl. .

Follow us on Twitter : [ Ссылка ]

Follow us on Koo : [ Ссылка ]

Follow us on Instagram :

/ freepressjo. .

Join us on Telegram Messenger : [ Ссылка ]

The Free Press Journal Epaper is now available on your Android phones & Tablets at no cost to download the app: [ Ссылка ]

Subscribe to our channels:
FPJ: [ Ссылка ]

свернуть